Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines

European Urology

Volumn 67, Issue 4, 2015, Pages 750-763

  Skolarikos, Andreas ^a   Straub, Michael ^b   Knoll, Thomas ^c   Sarica, Kemal ^d   Seitz, Christian ^e   Petřík, Ales ^f,g   Türk, Christian ^h  

^a SISMANOGLIO HOSPITAL   (Greece)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d Kartal Dr Lutfi KIrdar Training and Research Hospital   (Turkey)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f Regional Hospital   (Czech Republic)

^g CHARLES UNIVERSITY   (Czech Republic)

^h KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

Author keywords

European Association of Urology; Guidelines; Lithiasis; Medical treatment; Metabolic evaluation; Recurrence and conservative treatment; Stone; Urinary

Indexed keywords

CITRATE POTASSIUM; THIAZIDE DIURETIC AGENT; CALCIUM; CALCIUM DERIVATIVE; CALCIUM OXALATE; CALCIUM PHOSPHATE;

CALCIUM OXALATE STONE; CALCIUM PHOSPHATE STONE; CALCIUM STONE; DIETARY INTAKE; FLUID INTAKE; HIGH RISK POPULATION; HUMAN; HYPERCALCIURIA; HYPEROXALURIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STONE ANALYSIS; STONE FORMATION; URIC ACID STONE; URINALYSIS; UROLITHIASIS; ADULT; AGED; COMPLICATION; DRINKING; FEMALE; KIDNEY TUBULE ACIDOSIS; LIFESTYLE; MALE; META ANALYSIS; METABOLISM; MIDDLE AGED; RECURRENT DISEASE; URINARY CALCULI; URINE;

ACIDOSIS, RENAL TUBULAR; ADULT; AGED; CALCIUM; CALCIUM COMPOUNDS; CALCIUM OXALATE; CALCIUM PHOSPHATES; DRINKING; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; RECURRENCE; RISK FACTORS; URINARY CALCULI;

EID: 84923070268     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.10.029     Document Type: Article

References (99)

1. M.S. Pearle, E.A. Calhoun, and G.C. Curhan Urologic Diseases of America Project. Urologic diseases in America project: urolithiasis J Urol 173 2005 848 857
2. K.K. Stamatelou, M.E. Francis, C.A. Jones, L.M. Nyberg, and G.C. Curhan Time trends in reported prevalence of kidney stones in the United States: 1976-1994 Kidney Int 63 2003 1817 1823
3. J. Uribarri, M.S. Oh, and H.J. Carroll The first kidney stone Ann Intern Med 111 1989 1006 1009
4. G.C. Curhan, W.C. Willett, F.E. Speizer, and M.J. Stampfer Twenty-four-hour urine chemistries and the risk of kidney stones among women and men Kidney Int 59 2001 2290 2298
5. W.G. Robertson A risk factor model of stone-formation Front Biosci 8 2003 s1330 s1338
6. T. Yagisawa, P.S. Chandhoke, and J. Fan Metabolic risk factors in patients with first-time and recurrent stone formations as determined by comprehensive metabolic evaluation Urology 52 1998 750 755
7. J. Howick Levels of evidence 2009 Oxford Centre for Evidence-based Medicine Oxford, UK
8. A. Hesse, R. Kruse, W.J. Geilenkeuser, and M. Schmidt Quality control in urinary stone analysis: results of 44 ring trials (1980-2001) Clin Chem Lab Med 43 2005 298 303
9. J. Kourambas, P. Aslan, C.L. Teh, B.J. Mathias, and G.M. Preminger Role of stone analysis in metabolic evaluation and medical treatment of nephrolithiasis J Endourol 15 2001 181 186
10. N. Mandel, I. Mandel, K. Fryjoff, T. Rejniak, and G. Mandel Conversion of calcium oxalate to calcium phosphate with recurrent stone episodes J Urol 169 2003 2026 2029
11. M. Straub, W.L. Strohmaier, and W. Berg Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline World J Urol 23 2005 309 323
12. A. Trinchieri, F. Ostini, R. Nespoli, F. Rovera, E. Montanari, and G. Zanetti A prospective study of recurrence rate and risk factors for recurrence after a first renal stone J Urol 162 1999 27 30
13. J.H. Parks, E. Goldfisher, J.R. Asplin, and F.L. Coe A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis J Urol 167 2002 1607 1612
14. M. Nayan, M.A. Elkoushy, and S. Andonian Variations between two 24-hour urine collections in patients presenting to a tertiary stone clinic Can Urol Assoc J 6 2012 30 33
15. M.S. Pearle, C.G. Roehrborn, and C.Y. Pak Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis J Endourol 13 1999 679 685
16. F.L. Coe, A. Evan, and E. Worcester Kidney stone disease J Clin Invest 115 2005 2598 2608
17. R.W. Norman, S.S. Bath, W.G. Robertson, and M. Peacock When should patients with symptomatic urinary stone disease be evaluated metabolically? J Urol 132 1984 1137 1139
18. A.T. Hesse, H.-G. Tiselius, R. Siener, B.B. Hoppe, and H.E. Williams Urinary stones, diagnosis, treatment and prevention of recurrence ed 3. 2009 Karger AG Basel, Switzerland
19. R. Kocvara, P. Plasgura, A. Petrik, G. Louzensky, K. Bartonickova, and J. Dvoracek A prospective study of nonmedical prophylaxis after a first kidney stone BJU Int 84 1999 393 398
20. H.A. Fink, J.W. Akornor, and P.S. Garimella Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials Eur Urol 56 2009 72 80
21. E.N. Taylor, M.J. Stampfer, D.B. Mount, and G.C. Curhan DASH-style diet and 24-hour urine composition Clin J Am Soc Nephrol 5 2010 2315 2322
22. W. Qiang, and Z. Ke Water for preventing urinary calculi Cochrane Database Syst Rev 2004 CD004292
23. L. Borghi, T. Meschi, F. Amato, A. Briganti, A. Novarini, and A. Giannini Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study J Urol 155 1996 839 843
24. K. Sarica, Y. Inal, S. Erturhan, and F. Yagci The effect of calcium channel blockers on stone regrowth and recurrence after shock wave lithotripsy Urol Res 34 2006 184 189
25. G.C. Curhan, W.C. Willett, E.B. Rimm, D. Spiegelman, and M.J. Stampfer Prospective study of beverage use and the risk of kidney stones Am J Epidemiol 143 1996 240 247
26. H.K. Choi, and G. Curhan Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study BMJ 336 2008 309 312
27. B. Hess, H. Mauron, D. Ackermann, and P. Jaeger Effects of a "common sense diet" on urinary composition and supersaturation in patients with idiopathic calcium urolithiasis Eur Urol 36 1999 136 143
28. R.A. Hiatt, B. Ettinger, B. Caan, C.P. Quesenberry Jr., D. Duncan, and J.T. Citron Randomized controlled trial of a low animal protein, high fiber diet in the prevention of recurrent calcium oxalate kidney stones Am J Epidemiol 144 1996 25 33
29. L. Borghi, T. Schianchi, and T. Meschi Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria N Engl J Med 346 2002 77 84
30. E.N. Taylor, M.J. Stampfer, and G.C. Curhan Obesity, weight gain, and the risk of kidney stones JAMA 293 2005 455 462
31. L. Borghi, T. Meschi, A. Guerra, and A. Novarini Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences J Cardiovasc Pharmacol 22 Suppl 6 1993 S78 S86
32. P. Brocks, C. Dahl, H. Wolf, and I. Transbol Do thiazides prevent recurrent idiopathic renal calcium stones? Lancet 2 1981 124 125
33. B. Ettinger, J.T. Citron, B. Livermore, and L.I. Dolman Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not J Urol 139 1988 679 684
34. J.T. Mortensen, A. Schultz, and A.H. Ostergaard Thiazides in the prophylactic treatment of recurrent idiopathic kidney stones Int Urol Nephrol 18 1986 265 269
35. E. Laerum, and S. Larsen Thiazide prophylaxis of urolithiasis. A double-blind study in general practice Acta Med Scand 215 1984 383 389
36. M. Ohkawa, S. Tokunaga, T. Nakashima, M. Orito, and H. Hisazumi Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria Br J Urol 69 1992 571 576
37. W. Robertson, M. Peacock, and P.L. Selby A multicentre trial to evaluate three treatments for recurrent idiopathic calcium stone disease - a preliminary report P.O. Schwille, L.H. Smith, W.G. Robertson, W. Vahlensieck, Urolithiasis and related clinical research 1985 Plenum Press New York, NY 545 548
38. D. Scholz, P.O. Schwille, and A. Sigel Double-blind study with thiazide in recurrent calcium lithiasis J Urol 128 1982 903 907
39. D.R.S.A. Wilson, and M.A. Manuel Comparison of medical treatments for the prevention of recurrent calcium nephrolithiasis Urol Res 12 1984 39 40
40. P. Barcelo, O. Wuhl, E. Servitge, A. Rousaud, and C.Y. Pak Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis J Urol 150 1993 1761 1764
41. J. Hofbauer, K. Hobarth, N. Szabo, and M. Marberger Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis - a prospective randomized study Br J Urol 73 1994 362 365
42. B. Ettinger, C.Y. Pak, J.T. Citron, C. Thomas, B. Adams-Huet, and A. Vangessel Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis J Urol 158 1997 2069 2073
43. B. Ettinger, A. Tang, J.T. Citron, B. Livermore, and T. Williams Randomized trial of allopurinol in the prevention of calcium oxalate calculi N Engl J Med 315 1986 1386 1389
44. F.L. Coe Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder Ann Intern Med 87 1977 404 410
45. G. Johansson, U. Backman, B.G. Danielson, B. Fellstrom, S. Ljunghall, and B. Wikstrom Effects of magnesium hydroxide in renal stone disease J Am Coll Nutr 1 1982 179 185
46. Food and Nutrition Board, Institute of Medicine Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids 2000 National Academy Press Washington, DC
47. C.G. Monico, S. Rossetti, J.B. Olson, and D.S. Milliner Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele Kidney Int 67 2005 1704 1709
48. E.L. Prien Sr., and S.F. Gershoff Magnesium oxide-pyridoxine therapy for recurrent calcium oxalate calculi J Urol 112 1974 509 512
49. K. Jarrar, R.H. Boedeker, and W. Weidner Struvite stones: long term follow up under metaphylaxis Ann Urol (Paris) 30 1996 112 117
50. I. Wall, and H.G. Tiselius Long-term acidification of urine in patients treated for infected renal stones Urol Int 45 1990 336 341
51. D.P. Griffith, M.J. Gleeson, H. Lee, R. Longuet, E. Deman, and N. Earle Randomized, double-blind trial of Lithostat (acetohydroxamic acid) in the palliative treatment of infection-induced urinary calculi Eur Urol 20 1991 243 247
52. J.J. Williams, J.S. Rodman, and C.M. Peterson A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis N Engl J Med 311 1984 760 764
53. A. Rogers, S. Kalakish, R.A. Desai, and D.G. Assimos Management of cystinuria Urol Clin North Am 34 2007 347 362
54. C.Y. Pak, C. Fuller, K. Sakhaee, J.E. Zerwekh, and B.V. Adams Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine J Urol 136 1986 1003 1008
55. T.D. Cohen, S.B. Streem, and P. Hall Clinical effect of captopril on the formation and growth of cystine calculi J Urol 154 1995 164 166
56. J.Q. Stauffer Hyperoxaluria and intestinal disease. The role of steatorrhea and dietary calcium in regulating intestinal oxalate absorption Am J Dig Dis 22 1977 921 928
57. M.S.A.J. Pearle, F.L. Coe, A. Rodgers, E.M. Worcester (Committee 3) Medical management of urolithiasis J. Denstedt, S. Khoury, 2nd international consultation on stone disease 2008 Health Publications Plymouth, UK 57 84
58. O.W. Moe, M.S. Pearle, and K. Sakhaee Pharmacotherapy of urolithiasis: evidence from clinical trials Kidney Int 79 2011 385 392
59. E.M. Worcester, and F.L. Coe New insights into the pathogenesis of idiopathic hypercalciuria Semin Nephrol 28 2008 120 132
60. S.J. Silverberg, E. Shane, T.P. Jacobs, E. Siris, and J.P. Bilezikian A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery N Engl J Med 341 1999 1249 1255
61. F.L. Coe Hyperuricosuric calcium oxalate nephrolithiasis Kidney Int 13 1978 418 426
62. S. Domrongkitchaiporn, S. Khositseth, W. Stitchantrakul, W. Tapaneya-olarn, and P. Radinahamed Dosage of potassium citrate in the correction of urinary abnormalities in pediatric distal renal tubular acidosis patients Am J Kidney Dis 39 2002 383 391
63. A.P. Maxwell Genetic renal abnormalities Medicine 35 2007 386 392
64. B. Hoppe, B.B. Beck, and D.S. Milliner The primary hyperoxalurias Kidney Int 75 2009 1264 1271
65. B. Hoppe, E. Leumann, G. von Unruh, N. Laube, and A. Hesse Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria Front Biosci 8 2003 e437 e443
66. J.H. Parks, and F.L. Coe Evidence for durable kidney stone prevention over several decades BJU Int 103 2009 1238 1246
67. Y. Lotan, J.A. Cadeddu, C.G. Roerhborn, C.Y. Pak, and M.S. Pearle Cost-effectiveness of medical management strategies for nephrolithiasis J Urol 172 2004 2275 2281
68. A.E. Evan, J.E. Lingeman, and F.L. Coe Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones Kidney Int 74 2008 223 229
69. I. Blanco, J.M. Carril, and I. Banzo Double-phase Tc-99m sestamibi scintigraphy in the preoperative location of lesions causing hyperparathyroidism Clin Nucl Med 23 1998 291 297
70. G. Rizzato, and P. Colombo Nephrolithiasis as a presenting feature of chronic sarcoidosis: a prospective study Sarcoidosis Vasc Diffuse Lung Dis 13 1996 167 172
71. O.P. Sharma, and D. Vitamin calcium, and sarcoidosis Chest 109 1996 535 539
72. K. Takei, H. Ito, M. Masai, and T. Kotake Oral calcium supplement decreases urinary oxalate excretion in patients with enteric hyperoxaluria Urol Int 61 1998 192 195
73. E.A. Schell-Feith, A. Moerdijk, and P.H. van Zwieten Does citrate prevent nephrocalcinosis in preterm neonates? Pediatr Nephrol 21 2006 1830 1836
74. B. Hoppe, and M.J. Kemper Diagnostic examination of the child with urolithiasis or nephrocalcinosis Pediatr Nephrol 25 2010 403 413
75. M.A. Cameron, and K. Sakhaee Uric acid nephrolithiasis Urol Clin North Am 34 2007 335 346
76. Y.H. Chou, C.N. Huang, and W.M. Li Clinical study of ammonium acid urate urolithiasis Kaohsiung J Med Sci 28 2012 259 264
77. C.A. Wagner, and N. Mohebbi Urinary pH and stone formation J Nephrol 23 Suppl 16 2010 S165 S169
78. R. Miano, S. Germani, and G. Vespasiani Stones and urinary tract infections Urol Int 79 Suppl 1 2007 32 36
79. N.S. Mandel, and G.S. Mandel Urinary tract stone disease in the United States veteran population. II. Geographical analysis of variations in composition J Urol 142 1989 1516 1521
80. S. Millman, A.L. Strauss, J.H. Parks, and F.L. Coe Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis Kidney Int 22 1982 366 370
81. C.Y. Pak, J.R. Poindexter, R.D. Peterson, J. Koska, and K. Sakhaee Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis Urology 60 2002 789 794
82. M.T. Gettman, and J.W. Segura Struvite stones: diagnosis and current treatment concepts J Endourol 13 1999 653 658
83. K.H. Bichler, E. Eipper, K. Naber, V. Braun, R. Zimmermann, and S. Lahme Urinary infection stones Int J Antimicrob Agents 19 2002 488 498
84. X. Carpentier, M. Daudon, and O. Traxer Relationships between carbonation rate of carbapatite and morphologic characteristics of calcium phosphate stones and etiology Urology 73 2009 968 975
85. B.F. Schwartz, and M.L. Stoller Nonsurgical management of infection-related renal calculi Urol Clin North Am 26 1999 765 778
86. R.B. Thompson, and T.A. Stamey Bacteriology of infected stones Urology 2 1973 627 633
87. R.J. McLean, J.C. Nickel, K.J. Cheng, and J.W. Costerton The ecology and pathogenicity of urease-producing bacteria in the urinary tract Crit Rev Microbiol 16 1988 37 79
88. H.Y.R.C. Wong, and D.P. Griffith Medical management and prevention of struvite stones F.L. Coe, M.J. Favus, C.Y.C. Pak, J.H. Parks, G.M. Preminger, Kidney stones: medical and surgical management 1996 Lippincott-Raven Philadelphia, PA 941 950
89. L. Dello Strologo, E. Pras, and C. Pontesilli Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification J Am Soc Nephrol 13 2002 2547 2553
90. W.S. Lee, R.G. Wells, R.V. Sabbag, T.K. Mohandas, and M.A. Hediger Cloning and chromosomal localization of a human kidney cDNA involved in cystine, dibasic, and neutral amino acid transport J Clin Invest 91 1993 1959 1963
91. G. Becker Caring for Australians with Renal Impairment (CARI). The CARI guidelines. Kidney stones: cystine stones Nephrology (Carlton) 12 Suppl 1 2007 S4 10 [No abstract available]
92. T. Knoll, A. Zollner, G. Wendt-Nordahl, M.S. Michel, and P. Alken Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up Pediatr Nephrol 20 2005 19 24
93. R. Finocchiaro, P. D'Eufemia, and M. Celli Usefulness of cyanide-nitroprusside test in detecting incomplete recessive heterozygotes for cystinuria: a standardized dilution procedure Urol Res 26 1998 401 405
94. Y. Nakagawa, and F.L. Coe A modified cyanide-nitroprusside method for quantifying urinary cystine concentration that corrects for creatinine interference Clin Chim Acta 289 1999 57 68
95. M. Boutros, C. Vicanek, R. Rozen, and P. Goodyer Transient neonatal cystinuria Kidney Int 67 2005 443 448
96. C.S. Ng, and S.B. Streem Contemporary management of cystinuria J Endourol 13 1999 647 651
97. H.A. Fink, T.J. Wilt, and K.E. Eidman Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline Ann Intern Med 158 2013 535 543
98. J.W. Sutherland, J.H. Parks, and F.L. Coe Recurrence after a single renal stone in a community practice Miner Electrolyte Metab 11 1985 267 269
99. B. Ettinger Does hyperuricosuria play a role in calcium oxalate lithiasis? J Urol 141 1989 738 741